Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
24-26 February, 2026
Global ChemShowGlobal ChemShow
Not Confirmed
Not Confirmed
19-20 December, 2025
BIO Partnering at JPMBIO Partnering at JPM
Not Confirmed
Not Confirmed
12-15 January, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS





Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 February, 2026
Global ChemShowGlobal ChemShow
Industry Trade Show
Not Confirmed
19-20 December, 2025
BIO Partnering at JPMBIO Partnering at JPM
Industry Trade Show
Not Confirmed
12-15 January, 2026
Digital content

08 Dec 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/12/08/3201966/0/en/Protara-Announces-Closing-of-75-Million-Public-Offering.html

04 Dec 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/12/04/3200349/0/en/Protara-Announces-Proposed-Public-Offering.html

01 Dec 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/12/01/3197457/0/en/Protara-Therapeutics-to-Host-Conference-Call-and-Webcast-to-Review-New-Interim-Data-from-Phase-2-ADVANCED-2-Trial-of-TARA-002-in-BCG-Na%C3%AFve-NMIBC-Patients-on-Wednesday-December-3-20.html

19 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/19/3190887/0/en/Protara-Therapeutics-Announces-Positive-Interim-Results-Demonstrating-Robust-Responses-in-the-Ongoing-Phase-2-STARBORN-1-Trial-of-TARA-002-in-Pediatric-Patients-with-Lymphatic-Malf.html

18 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/18/3190507/0/en/Protara-Therapeutics-to-Host-Conference-Call-and-Webcast-to-Review-New-Interim-Data-from-Phase-2-STARBORN-1-Trial-of-TARA-002-in-Pediatric-Patients-with-Lymphatic-Malformations-on-.html

17 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/17/3189070/0/en/Protara-Therapeutics-to-Present-New-Interim-Data-from-Phase-2-ADVANCED-2-Trial-of-TARA-002-in-BCG-Na%C3%AFve-NMIBC-Patients-at-the-26th-Annual-Meeting-of-the-Society-of-Urologic-Oncolog.html
ABOUT THIS PAGE